Benzinga's Top Upgrades, Downgrades For December 6, 2018

Top Upgrades

  • Bank of America upgraded Arista Networks Inc ANET from Neutral to Buy. Arista shares fell 1.9 percent to $225.44 in pre-market trading.
  • JP Morgan upgraded Activision Blizzard, Inc. ATVI from Neutral to Overweight. Activision shares rose 0.5 percent to $46.74 in pre-market trading.
  • Credit Suisse upgraded Spirit Airlines Incorporated SAVE from Neutral to Outperform. Spirit Airlines shares rose 2.7 percent to $64.80 in pre-market trading.
  • JP Morgan upgraded Hostess Brands Inc TWNK from Neutral to Overweight. Hostess Brands rose 0.4 percent to $11.32 in pre-market trading.
  • Baird upgraded American Water Works Company Inc AWK from Neutral to Outperform. American Water Works shares rose 0.08 percent to close at $95.78 on Tuesday.
  • Analysts at BMO Capital upgraded Bristol-Myers Squibb Co BMY from Market Perform to Outperform. Bristol-Myers shares fell 0.01 percent to $52.02 in pre-market trading.
  • Pivotal Research upgraded Columbia Sportswear Company COLM from Hold to Buy. Columbia Sportswear shares fell 0.7 percent to $91.65 in pre-market trading.
  • Goldman Sachs upgraded YY Inc YY from Neutral to Buy. YY shares fell 3.3 percent to $63.78 in pre-market trading.
  • Nomura upgraded Vulcan Materials Company VMC from Neutral to Buy. Vulcan Materials shares rose 0.8 percent to $101.39 in pre-market trading.
  • Morgan Stanley upgraded NetEase Inc NTES from Equal-Weight to Overweight. NetEase shares fell 3 percent to $222.49 in pre-market trading.

 

Top Downgrades

  • Barclays downgraded GlaxoSmithKline plc GSK from Overweight to Equal-Weight. GlaxoSmithKline shares fell 3.6 percent to $36.95 in pre-market trading.
  • Stifel Nicolaus downgraded Facebook, Inc. FB from Buy to Hold. Facebook shares fell 2.7 percent to $134.27 in pre-market trading.
  • Piper Jaffray downgraded bluebird bio Inc BLUE from Overweight to Neutral. bluebird shares fell 2.5 percent to $110.78 in pre-market trading.
  • Stifel Nicolaus downgraded Conatus Pharmaceuticals Inc CNAT from Buy to Hold. Conatus Pharmaceuticals shares fell 56.2 percent to $1.97 in pre-market trading.
  • Atlantic Equities downgraded Macy's Inc M from Neutral to Underweight. Macy's shares fell 2.3 percent to $31.69 in pre-market trading.
  • RBC Capital downgraded Toll Brothers Inc TOL from Outperform to Sector Perform. Toll Brothers shares fell 1.8 percent to $32.41 in pre-market trading.
  • Morgan Stanley downgraded Autoliv Inc. ALV from Overweight to Equal-Weight. Autoliv shares fell 4 percent to $82.80 in pre-market trading.
  • Wells Fargo downgraded Oncomed Pharmaceuticals Inc OMED from Outperform to Market Perform. OncoMed Pharmaceuticals shares rose 30.6 percent to $1.45 in pre-market trading.
  • B. Riley FBR downgraded NeoPhotonics Corp NPTN from Buy to Neutral. NeoPhotonics shares fell 18.6 percent to $6.30 in pre-market trading.
  • MKM Partners downgraded Finisar Corporation FNSR from Buy to Neutral. Finisar shares fell 7.8 percent to $21.08 in pre-market trading.

 

Top Initiations

  • Analysts at Guggenheim initiated coverage on Alphabet Inc GOOGL with a Buy rating. The price target for Alphabet is set to $1,330. Alphabet shares closed at $1,062.47 on Tuesday.
  • Berenberg initiated coverage on Allegheny Technologies Incorporated ATI with a Buy rating. The price target for Allegheny Technologies is set to $35. Allegheny Technologies shares closed at $25.74 on Tuesday.
  • Guggenheim initiated coverage on Snap Inc SNAP with a Neutral rating. The price target for Snap is set to $6. Snap shares closed at $6.21 on Tuesday.
  • Imperial Capital initiated coverage on Haymaker Acquisition Corp. HYAC with an Outperform rating. The price target for Haymaker Acquisition is set to $14. Haymaker Acquisition shares closed at $10.05 on Tuesday.
  • Analysts at Guggenheim initiated coverage on Facebook, Inc. FB with a Neutral rating. The price target for Facebook is set to $150. Facebook closed at $137.93 on Tuesday.
  • Analysts at Roth Capital initiated coverage on BioSig Technologies Inc BSGM with a Buy rating. The price target for BioSig Technologies is set to $14. BioSig Technologies shares closed at $3.97 on Tuesday.
  • Guggenheim initiated coverage on Twitter Inc TWTR with a Buy rating. The price target for Twitter is set to $39. Twitter closed at $32.56 on Tuesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesDowngradesInitiationPre-Market OutlookAnalyst RatingsConsumer DiscretionaryDepartment StoresInitiationstop upgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!